nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—stomach cancer	0.368	0.78	CbGaD
Clomipramine—ALB—stomach cancer	0.104	0.22	CbGaD
Clomipramine—ABCB1—Mitomycin—stomach cancer	0.0525	0.27	CbGbCtD
Clomipramine—ALB—Irinotecan—stomach cancer	0.0258	0.132	CbGbCtD
Clomipramine—ALB—Fluorouracil—stomach cancer	0.0247	0.127	CbGbCtD
Clomipramine—HRH2—gastric juice—stomach cancer	0.0169	0.276	CbGeAlD
Clomipramine—CYP1A2—Fluorouracil—stomach cancer	0.0148	0.076	CbGbCtD
Clomipramine—ALB—Methotrexate—stomach cancer	0.0136	0.0701	CbGbCtD
Clomipramine—ABCB1—Irinotecan—stomach cancer	0.0135	0.0692	CbGbCtD
Clomipramine—ABCB1—Docetaxel—stomach cancer	0.00988	0.0507	CbGbCtD
Clomipramine—CYP3A4—Irinotecan—stomach cancer	0.00808	0.0415	CbGbCtD
Clomipramine—ABCB1—Doxorubicin—stomach cancer	0.00736	0.0378	CbGbCtD
Clomipramine—ABCB1—Methotrexate—stomach cancer	0.00713	0.0366	CbGbCtD
Clomipramine—CYP2D6—Doxorubicin—stomach cancer	0.00694	0.0356	CbGbCtD
Clomipramine—CYP3A4—Docetaxel—stomach cancer	0.00592	0.0304	CbGbCtD
Clomipramine—CYP3A4—Doxorubicin—stomach cancer	0.00441	0.0227	CbGbCtD
Clomipramine—HTR2A—myenteric nerve plexus—stomach cancer	0.00432	0.0704	CbGeAlD
Clomipramine—HTR2A—vagus nerve—stomach cancer	0.00288	0.047	CbGeAlD
Clomipramine—HTR2A—vein—stomach cancer	0.00279	0.0454	CbGeAlD
Clomipramine—GSTP1—gall bladder—stomach cancer	0.00189	0.0308	CbGeAlD
Clomipramine—ALB—gall bladder—stomach cancer	0.00162	0.0264	CbGeAlD
Clomipramine—HRH2—hematopoietic system—stomach cancer	0.00149	0.0242	CbGeAlD
Clomipramine—GSTP1—hematopoietic system—stomach cancer	0.00107	0.0174	CbGeAlD
Clomipramine—HRH2—digestive system—stomach cancer	0.00103	0.0168	CbGeAlD
Clomipramine—GSTP1—epithelium—stomach cancer	0.000978	0.0159	CbGeAlD
Clomipramine—GSTP1—smooth muscle tissue—stomach cancer	0.000942	0.0153	CbGeAlD
Clomipramine—SLC6A4—hematopoietic system—stomach cancer	0.00089	0.0145	CbGeAlD
Clomipramine—HTR2A—blood vessel—stomach cancer	0.000884	0.0144	CbGeAlD
Clomipramine—GSTP1—pancreas—stomach cancer	0.000871	0.0142	CbGeAlD
Clomipramine—HRH2—endocrine gland—stomach cancer	0.000853	0.0139	CbGeAlD
Clomipramine—HTR2B—smooth muscle tissue—stomach cancer	0.000777	0.0126	CbGeAlD
Clomipramine—HRH2—liver—stomach cancer	0.00077	0.0125	CbGeAlD
Clomipramine—GSTP1—lymphoid tissue—stomach cancer	0.000753	0.0123	CbGeAlD
Clomipramine—GSTP1—digestive system—stomach cancer	0.000744	0.0121	CbGeAlD
Clomipramine—CYP2C19—hematopoietic system—stomach cancer	0.000737	0.012	CbGeAlD
Clomipramine—GSTP1—bone marrow—stomach cancer	0.000686	0.0112	CbGeAlD
Clomipramine—SLC6A4—digestive system—stomach cancer	0.000619	0.0101	CbGeAlD
Clomipramine—GSTP1—endocrine gland—stomach cancer	0.000615	0.01	CbGeAlD
Clomipramine—HTR2B—digestive system—stomach cancer	0.000613	0.00999	CbGeAlD
Clomipramine—CYP1A2—hematopoietic system—stomach cancer	0.000602	0.00981	CbGeAlD
Clomipramine—HRH2—lymph node—stomach cancer	0.00059	0.00961	CbGeAlD
Clomipramine—ABCB1—blood vessel—stomach cancer	0.000579	0.00944	CbGeAlD
Clomipramine—GSTP1—liver—stomach cancer	0.000554	0.00902	CbGeAlD
Clomipramine—ADRA2A—hematopoietic system—stomach cancer	0.000554	0.00902	CbGeAlD
Clomipramine—CYP2C19—digestive system—stomach cancer	0.000513	0.00835	CbGeAlD
Clomipramine—SLC6A4—endocrine gland—stomach cancer	0.000511	0.00833	CbGeAlD
Clomipramine—ALB—liver—stomach cancer	0.000474	0.00773	CbGeAlD
Clomipramine—HTR2A—hematopoietic system—stomach cancer	0.000471	0.00767	CbGeAlD
Clomipramine—ADRA2A—pancreas—stomach cancer	0.000451	0.00734	CbGeAlD
Clomipramine—SLC6A2—endocrine gland—stomach cancer	0.00045	0.00733	CbGeAlD
Clomipramine—CYP3A4—hematopoietic system—stomach cancer	0.000436	0.0071	CbGeAlD
Clomipramine—HTR2A—epithelium—stomach cancer	0.00043	0.00701	CbGeAlD
Clomipramine—CYP2D6—hematopoietic system—stomach cancer	0.000429	0.00699	CbGeAlD
Clomipramine—GSTP1—lymph node—stomach cancer	0.000425	0.00692	CbGeAlD
Clomipramine—CYP2C19—endocrine gland—stomach cancer	0.000424	0.0069	CbGeAlD
Clomipramine—CYP1A2—digestive system—stomach cancer	0.000419	0.00682	CbGeAlD
Clomipramine—HTR2A—smooth muscle tissue—stomach cancer	0.000415	0.00675	CbGeAlD
Clomipramine—CYP2C19—liver—stomach cancer	0.000382	0.00622	CbGeAlD
Clomipramine—Promethazine—HRH4—stomach cancer	0.000367	0.103	CrCbGaD
Clomipramine—ALB—lymph node—stomach cancer	0.000364	0.00592	CbGeAlD
Clomipramine—Doxepin—HRH4—stomach cancer	0.000364	0.102	CrCbGaD
Clomipramine—HTR2B—lymph node—stomach cancer	0.00035	0.0057	CbGeAlD
Clomipramine—CYP1A2—endocrine gland—stomach cancer	0.000346	0.00564	CbGeAlD
Clomipramine—HTR2A—digestive system—stomach cancer	0.000327	0.00533	CbGeAlD
Clomipramine—ADRA2A—endocrine gland—stomach cancer	0.000318	0.00518	CbGeAlD
Clomipramine—CYP1A2—liver—stomach cancer	0.000312	0.00508	CbGeAlD
Clomipramine—SLC6A2—lymph node—stomach cancer	0.000311	0.00507	CbGeAlD
Clomipramine—ABCB1—hematopoietic system—stomach cancer	0.000309	0.00503	CbGeAlD
Clomipramine—CYP3A4—digestive system—stomach cancer	0.000303	0.00494	CbGeAlD
Clomipramine—CYP2D6—digestive system—stomach cancer	0.000298	0.00486	CbGeAlD
Clomipramine—Chlorpromazine—HRH4—stomach cancer	0.000285	0.0797	CrCbGaD
Clomipramine—ABCB1—epithelium—stomach cancer	0.000282	0.00459	CbGeAlD
Clomipramine—Amitriptyline—HRH4—stomach cancer	0.000281	0.0788	CrCbGaD
Clomipramine—HTR2A—endocrine gland—stomach cancer	0.000271	0.00441	CbGeAlD
Clomipramine—ABCB1—pancreas—stomach cancer	0.000251	0.00409	CbGeAlD
Clomipramine—CYP3A4—endocrine gland—stomach cancer	0.000251	0.00408	CbGeAlD
Clomipramine—CYP2D6—endocrine gland—stomach cancer	0.000247	0.00401	CbGeAlD
Clomipramine—HTR2A—liver—stomach cancer	0.000244	0.00397	CbGeAlD
Clomipramine—CYP3A4—liver—stomach cancer	0.000226	0.00368	CbGeAlD
Clomipramine—CYP2D6—liver—stomach cancer	0.000222	0.00362	CbGeAlD
Clomipramine—ADRA2A—lymph node—stomach cancer	0.00022	0.00358	CbGeAlD
Clomipramine—ABCB1—lymphoid tissue—stomach cancer	0.000217	0.00354	CbGeAlD
Clomipramine—ABCB1—digestive system—stomach cancer	0.000215	0.00349	CbGeAlD
Clomipramine—ABCB1—bone marrow—stomach cancer	0.000198	0.00322	CbGeAlD
Clomipramine—ABCB1—endocrine gland—stomach cancer	0.000177	0.00289	CbGeAlD
Clomipramine—ABCB1—liver—stomach cancer	0.00016	0.0026	CbGeAlD
Clomipramine—Acepromazine—HTR1A—stomach cancer	0.000158	0.0442	CrCbGaD
Clomipramine—Thioproperazine—HTR1A—stomach cancer	0.000154	0.0432	CrCbGaD
Clomipramine—Pipotiazine—HTR1A—stomach cancer	0.000152	0.0425	CrCbGaD
Clomipramine—Flurazepam—CYP2A6—stomach cancer	0.000128	0.0359	CrCbGaD
Clomipramine—ABCB1—lymph node—stomach cancer	0.000123	0.002	CbGeAlD
Clomipramine—Nortriptyline—HTR1A—stomach cancer	0.000117	0.0328	CrCbGaD
Clomipramine—Thioridazine—HTR1A—stomach cancer	0.000113	0.0317	CrCbGaD
Clomipramine—Desipramine—CYP2A6—stomach cancer	0.000111	0.0311	CrCbGaD
Clomipramine—Trimipramine—HTR1A—stomach cancer	0.00011	0.0309	CrCbGaD
Clomipramine—Desipramine—ADRB1—stomach cancer	0.000108	0.0302	CrCbGaD
Clomipramine—Doxepin—HTR1A—stomach cancer	0.000105	0.0295	CrCbGaD
Clomipramine—Trifluoperazine—HTR1A—stomach cancer	0.000105	0.0294	CrCbGaD
Clomipramine—Perphenazine—HTR1A—stomach cancer	0.000104	0.029	CrCbGaD
Clomipramine—Desipramine—HTR1A—stomach cancer	9.65e-05	0.027	CrCbGaD
Clomipramine—Desipramine—ADRB2—stomach cancer	9.07e-05	0.0254	CrCbGaD
Clomipramine—Chlorpromazine—HTR1A—stomach cancer	8.22e-05	0.023	CrCbGaD
Clomipramine—Imipramine—HTR1A—stomach cancer	8.18e-05	0.0229	CrCbGaD
Clomipramine—Amitriptyline—HTR1A—stomach cancer	8.13e-05	0.0228	CrCbGaD
Clomipramine—Acepromazine—ALB—stomach cancer	7.08e-05	0.0198	CrCbGaD
Clomipramine—Thioproperazine—ALB—stomach cancer	6.92e-05	0.0194	CrCbGaD
Clomipramine—Pipotiazine—ALB—stomach cancer	6.81e-05	0.0191	CrCbGaD
Clomipramine—Dyspepsia—Docetaxel—stomach cancer	6.48e-05	0.000352	CcSEcCtD
Clomipramine—Hepatitis—Doxorubicin—stomach cancer	6.47e-05	0.000351	CcSEcCtD
Clomipramine—Insomnia—Capecitabine—stomach cancer	6.45e-05	0.00035	CcSEcCtD
Clomipramine—Hypoaesthesia—Doxorubicin—stomach cancer	6.44e-05	0.00035	CcSEcCtD
Clomipramine—Rash—Fluorouracil—stomach cancer	6.43e-05	0.000349	CcSEcCtD
Clomipramine—Dermatitis—Fluorouracil—stomach cancer	6.43e-05	0.000349	CcSEcCtD
Clomipramine—Pharyngitis—Doxorubicin—stomach cancer	6.42e-05	0.000349	CcSEcCtD
Clomipramine—Paraesthesia—Capecitabine—stomach cancer	6.4e-05	0.000348	CcSEcCtD
Clomipramine—Decreased appetite—Docetaxel—stomach cancer	6.4e-05	0.000348	CcSEcCtD
Clomipramine—Headache—Fluorouracil—stomach cancer	6.39e-05	0.000347	CcSEcCtD
Clomipramine—Urinary tract disorder—Doxorubicin—stomach cancer	6.39e-05	0.000347	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—stomach cancer	6.37e-05	0.000346	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Docetaxel—stomach cancer	6.36e-05	0.000345	CcSEcCtD
Clomipramine—Connective tissue disorder—Doxorubicin—stomach cancer	6.36e-05	0.000345	CcSEcCtD
Clomipramine—Dyspnoea—Capecitabine—stomach cancer	6.36e-05	0.000345	CcSEcCtD
Clomipramine—Fatigue—Docetaxel—stomach cancer	6.35e-05	0.000345	CcSEcCtD
Clomipramine—Angiopathy—Epirubicin—stomach cancer	6.34e-05	0.000344	CcSEcCtD
Clomipramine—Urethral disorder—Doxorubicin—stomach cancer	6.34e-05	0.000344	CcSEcCtD
Clomipramine—Nausea—Irinotecan—stomach cancer	6.33e-05	0.000344	CcSEcCtD
Clomipramine—Immune system disorder—Epirubicin—stomach cancer	6.31e-05	0.000343	CcSEcCtD
Clomipramine—Mediastinal disorder—Epirubicin—stomach cancer	6.3e-05	0.000342	CcSEcCtD
Clomipramine—Constipation—Docetaxel—stomach cancer	6.3e-05	0.000342	CcSEcCtD
Clomipramine—Pain—Docetaxel—stomach cancer	6.3e-05	0.000342	CcSEcCtD
Clomipramine—Back pain—Methotrexate—stomach cancer	6.29e-05	0.000342	CcSEcCtD
Clomipramine—Dyspepsia—Capecitabine—stomach cancer	6.28e-05	0.000341	CcSEcCtD
Clomipramine—Chills—Epirubicin—stomach cancer	6.27e-05	0.000341	CcSEcCtD
Clomipramine—Arrhythmia—Epirubicin—stomach cancer	6.25e-05	0.000339	CcSEcCtD
Clomipramine—Visual impairment—Doxorubicin—stomach cancer	6.23e-05	0.000339	CcSEcCtD
Clomipramine—Decreased appetite—Capecitabine—stomach cancer	6.2e-05	0.000337	CcSEcCtD
Clomipramine—Alopecia—Epirubicin—stomach cancer	6.18e-05	0.000335	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Capecitabine—stomach cancer	6.16e-05	0.000334	CcSEcCtD
Clomipramine—Fatigue—Capecitabine—stomach cancer	6.15e-05	0.000334	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—stomach cancer	6.13e-05	0.000333	CcSEcCtD
Clomipramine—Mental disorder—Epirubicin—stomach cancer	6.12e-05	0.000333	CcSEcCtD
Clomipramine—Pain—Capecitabine—stomach cancer	6.1e-05	0.000331	CcSEcCtD
Clomipramine—Constipation—Capecitabine—stomach cancer	6.1e-05	0.000331	CcSEcCtD
Clomipramine—Malnutrition—Epirubicin—stomach cancer	6.09e-05	0.00033	CcSEcCtD
Clomipramine—Feeling abnormal—Docetaxel—stomach cancer	6.07e-05	0.00033	CcSEcCtD
Clomipramine—Nausea—Fluorouracil—stomach cancer	6.06e-05	0.000329	CcSEcCtD
Clomipramine—Eye disorder—Doxorubicin—stomach cancer	6.05e-05	0.000328	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—stomach cancer	6.03e-05	0.000328	CcSEcCtD
Clomipramine—Tinnitus—Doxorubicin—stomach cancer	6.03e-05	0.000328	CcSEcCtD
Clomipramine—Gastrointestinal pain—Docetaxel—stomach cancer	6.02e-05	0.000327	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—stomach cancer	6.01e-05	0.000326	CcSEcCtD
Clomipramine—Cardiac disorder—Doxorubicin—stomach cancer	6e-05	0.000326	CcSEcCtD
Clomipramine—Flushing—Doxorubicin—stomach cancer	6e-05	0.000326	CcSEcCtD
Clomipramine—Flatulence—Epirubicin—stomach cancer	6e-05	0.000326	CcSEcCtD
Clomipramine—Tension—Epirubicin—stomach cancer	5.97e-05	0.000324	CcSEcCtD
Clomipramine—Dysgeusia—Epirubicin—stomach cancer	5.96e-05	0.000324	CcSEcCtD
Clomipramine—Nervousness—Epirubicin—stomach cancer	5.91e-05	0.000321	CcSEcCtD
Clomipramine—Back pain—Epirubicin—stomach cancer	5.89e-05	0.00032	CcSEcCtD
Clomipramine—Feeling abnormal—Capecitabine—stomach cancer	5.88e-05	0.000319	CcSEcCtD
Clomipramine—Angiopathy—Doxorubicin—stomach cancer	5.87e-05	0.000319	CcSEcCtD
Clomipramine—Malaise—Methotrexate—stomach cancer	5.86e-05	0.000318	CcSEcCtD
Clomipramine—Muscle spasms—Epirubicin—stomach cancer	5.85e-05	0.000318	CcSEcCtD
Clomipramine—Immune system disorder—Doxorubicin—stomach cancer	5.84e-05	0.000317	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—stomach cancer	5.84e-05	0.000317	CcSEcCtD
Clomipramine—Gastrointestinal pain—Capecitabine—stomach cancer	5.83e-05	0.000317	CcSEcCtD
Clomipramine—Mediastinal disorder—Doxorubicin—stomach cancer	5.83e-05	0.000317	CcSEcCtD
Clomipramine—Abdominal pain—Docetaxel—stomach cancer	5.82e-05	0.000316	CcSEcCtD
Clomipramine—Body temperature increased—Docetaxel—stomach cancer	5.82e-05	0.000316	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—stomach cancer	5.82e-05	0.000316	CcSEcCtD
Clomipramine—Chills—Doxorubicin—stomach cancer	5.8e-05	0.000315	CcSEcCtD
Clomipramine—Arrhythmia—Doxorubicin—stomach cancer	5.78e-05	0.000314	CcSEcCtD
Clomipramine—Vision blurred—Epirubicin—stomach cancer	5.74e-05	0.000311	CcSEcCtD
Clomipramine—Alopecia—Doxorubicin—stomach cancer	5.72e-05	0.00031	CcSEcCtD
Clomipramine—Cough—Methotrexate—stomach cancer	5.67e-05	0.000308	CcSEcCtD
Clomipramine—Mental disorder—Doxorubicin—stomach cancer	5.67e-05	0.000308	CcSEcCtD
Clomipramine—Urticaria—Capecitabine—stomach cancer	5.66e-05	0.000308	CcSEcCtD
Clomipramine—Ill-defined disorder—Epirubicin—stomach cancer	5.65e-05	0.000307	CcSEcCtD
Clomipramine—Body temperature increased—Capecitabine—stomach cancer	5.64e-05	0.000306	CcSEcCtD
Clomipramine—Abdominal pain—Capecitabine—stomach cancer	5.64e-05	0.000306	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—stomach cancer	5.63e-05	0.000306	CcSEcCtD
Clomipramine—Malnutrition—Doxorubicin—stomach cancer	5.63e-05	0.000306	CcSEcCtD
Clomipramine—Anaemia—Epirubicin—stomach cancer	5.62e-05	0.000305	CcSEcCtD
Clomipramine—Agitation—Epirubicin—stomach cancer	5.59e-05	0.000304	CcSEcCtD
Clomipramine—Flatulence—Doxorubicin—stomach cancer	5.55e-05	0.000301	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—stomach cancer	5.54e-05	0.000301	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—stomach cancer	5.54e-05	0.000301	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—stomach cancer	5.54e-05	0.000301	CcSEcCtD
Clomipramine—Tension—Doxorubicin—stomach cancer	5.53e-05	0.0003	CcSEcCtD
Clomipramine—Dysgeusia—Doxorubicin—stomach cancer	5.51e-05	0.000299	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.5e-05	0.000299	CcSEcCtD
Clomipramine—Malaise—Epirubicin—stomach cancer	5.49e-05	0.000298	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—stomach cancer	5.47e-05	0.000297	CcSEcCtD
Clomipramine—Nervousness—Doxorubicin—stomach cancer	5.47e-05	0.000297	CcSEcCtD
Clomipramine—Vertigo—Epirubicin—stomach cancer	5.47e-05	0.000297	CcSEcCtD
Clomipramine—Syncope—Epirubicin—stomach cancer	5.46e-05	0.000296	CcSEcCtD
Clomipramine—Leukopenia—Epirubicin—stomach cancer	5.45e-05	0.000296	CcSEcCtD
Clomipramine—Back pain—Doxorubicin—stomach cancer	5.45e-05	0.000296	CcSEcCtD
Clomipramine—Hypersensitivity—Docetaxel—stomach cancer	5.43e-05	0.000295	CcSEcCtD
Clomipramine—Muscle spasms—Doxorubicin—stomach cancer	5.41e-05	0.000294	CcSEcCtD
Clomipramine—Palpitations—Epirubicin—stomach cancer	5.38e-05	0.000292	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—stomach cancer	5.35e-05	0.000291	CcSEcCtD
Clomipramine—Loss of consciousness—Epirubicin—stomach cancer	5.35e-05	0.00029	CcSEcCtD
Clomipramine—Cough—Epirubicin—stomach cancer	5.31e-05	0.000288	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—stomach cancer	5.31e-05	0.000288	CcSEcCtD
Clomipramine—Vision blurred—Doxorubicin—stomach cancer	5.31e-05	0.000288	CcSEcCtD
Clomipramine—Asthenia—Docetaxel—stomach cancer	5.28e-05	0.000287	CcSEcCtD
Clomipramine—Convulsion—Epirubicin—stomach cancer	5.27e-05	0.000286	CcSEcCtD
Clomipramine—Nortriptyline—ALB—stomach cancer	5.26e-05	0.0147	CrCbGaD
Clomipramine—Hypertension—Epirubicin—stomach cancer	5.25e-05	0.000285	CcSEcCtD
Clomipramine—Hypersensitivity—Capecitabine—stomach cancer	5.25e-05	0.000285	CcSEcCtD
Clomipramine—Ill-defined disorder—Doxorubicin—stomach cancer	5.22e-05	0.000284	CcSEcCtD
Clomipramine—Pruritus—Docetaxel—stomach cancer	5.21e-05	0.000283	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—stomach cancer	5.2e-05	0.000283	CcSEcCtD
Clomipramine—Anaemia—Doxorubicin—stomach cancer	5.2e-05	0.000283	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—stomach cancer	5.2e-05	0.000282	CcSEcCtD
Clomipramine—Arthralgia—Epirubicin—stomach cancer	5.18e-05	0.000281	CcSEcCtD
Clomipramine—Chest pain—Epirubicin—stomach cancer	5.18e-05	0.000281	CcSEcCtD
Clomipramine—Myalgia—Epirubicin—stomach cancer	5.18e-05	0.000281	CcSEcCtD
Clomipramine—Agitation—Doxorubicin—stomach cancer	5.17e-05	0.000281	CcSEcCtD
Clomipramine—Anxiety—Epirubicin—stomach cancer	5.16e-05	0.00028	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—stomach cancer	5.16e-05	0.00028	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.15e-05	0.000279	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—stomach cancer	5.13e-05	0.000279	CcSEcCtD
Clomipramine—Discomfort—Epirubicin—stomach cancer	5.12e-05	0.000278	CcSEcCtD
Clomipramine—Asthenia—Capecitabine—stomach cancer	5.12e-05	0.000278	CcSEcCtD
Clomipramine—Malaise—Doxorubicin—stomach cancer	5.08e-05	0.000276	CcSEcCtD
Clomipramine—Dry mouth—Epirubicin—stomach cancer	5.07e-05	0.000275	CcSEcCtD
Clomipramine—Vertigo—Doxorubicin—stomach cancer	5.06e-05	0.000275	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—stomach cancer	5.06e-05	0.000275	CcSEcCtD
Clomipramine—Syncope—Doxorubicin—stomach cancer	5.05e-05	0.000274	CcSEcCtD
Clomipramine—Pruritus—Capecitabine—stomach cancer	5.04e-05	0.000274	CcSEcCtD
Clomipramine—Leukopenia—Doxorubicin—stomach cancer	5.04e-05	0.000274	CcSEcCtD
Clomipramine—Diarrhoea—Docetaxel—stomach cancer	5.04e-05	0.000274	CcSEcCtD
Clomipramine—Confusional state—Epirubicin—stomach cancer	5.01e-05	0.000272	CcSEcCtD
Clomipramine—Palpitations—Doxorubicin—stomach cancer	4.98e-05	0.00027	CcSEcCtD
Clomipramine—Anaphylactic shock—Epirubicin—stomach cancer	4.97e-05	0.00027	CcSEcCtD
Clomipramine—Oedema—Epirubicin—stomach cancer	4.97e-05	0.00027	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—stomach cancer	4.96e-05	0.000269	CcSEcCtD
Clomipramine—Loss of consciousness—Doxorubicin—stomach cancer	4.95e-05	0.000269	CcSEcCtD
Clomipramine—Cough—Doxorubicin—stomach cancer	4.91e-05	0.000267	CcSEcCtD
Clomipramine—Shock—Epirubicin—stomach cancer	4.89e-05	0.000265	CcSEcCtD
Clomipramine—Convulsion—Doxorubicin—stomach cancer	4.88e-05	0.000265	CcSEcCtD
Clomipramine—Diarrhoea—Capecitabine—stomach cancer	4.88e-05	0.000265	CcSEcCtD
Clomipramine—Nervous system disorder—Epirubicin—stomach cancer	4.87e-05	0.000265	CcSEcCtD
Clomipramine—Dizziness—Docetaxel—stomach cancer	4.87e-05	0.000264	CcSEcCtD
Clomipramine—Thrombocytopenia—Epirubicin—stomach cancer	4.86e-05	0.000264	CcSEcCtD
Clomipramine—Hypertension—Doxorubicin—stomach cancer	4.86e-05	0.000264	CcSEcCtD
Clomipramine—Tachycardia—Epirubicin—stomach cancer	4.85e-05	0.000263	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.84e-05	0.000263	CcSEcCtD
Clomipramine—Skin disorder—Epirubicin—stomach cancer	4.82e-05	0.000262	CcSEcCtD
Clomipramine—Hyperhidrosis—Epirubicin—stomach cancer	4.8e-05	0.000261	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—stomach cancer	4.8e-05	0.000261	CcSEcCtD
Clomipramine—Myalgia—Doxorubicin—stomach cancer	4.79e-05	0.00026	CcSEcCtD
Clomipramine—Arthralgia—Doxorubicin—stomach cancer	4.79e-05	0.00026	CcSEcCtD
Clomipramine—Chest pain—Doxorubicin—stomach cancer	4.79e-05	0.00026	CcSEcCtD
Clomipramine—Anxiety—Doxorubicin—stomach cancer	4.78e-05	0.000259	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—stomach cancer	4.77e-05	0.000259	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.76e-05	0.000259	CcSEcCtD
Clomipramine—Discomfort—Doxorubicin—stomach cancer	4.74e-05	0.000257	CcSEcCtD
Clomipramine—Anorexia—Epirubicin—stomach cancer	4.73e-05	0.000257	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—stomach cancer	4.73e-05	0.000257	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—stomach cancer	4.72e-05	0.000256	CcSEcCtD
Clomipramine—Dizziness—Capecitabine—stomach cancer	4.71e-05	0.000256	CcSEcCtD
Clomipramine—Dry mouth—Doxorubicin—stomach cancer	4.69e-05	0.000255	CcSEcCtD
Clomipramine—Vomiting—Docetaxel—stomach cancer	4.68e-05	0.000254	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—stomach cancer	4.67e-05	0.000254	CcSEcCtD
Clomipramine—Rash—Docetaxel—stomach cancer	4.64e-05	0.000252	CcSEcCtD
Clomipramine—Hypotension—Epirubicin—stomach cancer	4.64e-05	0.000252	CcSEcCtD
Clomipramine—Dermatitis—Docetaxel—stomach cancer	4.64e-05	0.000252	CcSEcCtD
Clomipramine—Confusional state—Doxorubicin—stomach cancer	4.63e-05	0.000252	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—stomach cancer	4.61e-05	0.000251	CcSEcCtD
Clomipramine—Headache—Docetaxel—stomach cancer	4.61e-05	0.000251	CcSEcCtD
Clomipramine—Anaphylactic shock—Doxorubicin—stomach cancer	4.6e-05	0.00025	CcSEcCtD
Clomipramine—Oedema—Doxorubicin—stomach cancer	4.6e-05	0.00025	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—stomach cancer	4.58e-05	0.000249	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—stomach cancer	4.58e-05	0.000248	CcSEcCtD
Clomipramine—Pain—Methotrexate—stomach cancer	4.54e-05	0.000246	CcSEcCtD
Clomipramine—Vomiting—Capecitabine—stomach cancer	4.53e-05	0.000246	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.53e-05	0.000246	CcSEcCtD
Clomipramine—Shock—Doxorubicin—stomach cancer	4.52e-05	0.000246	CcSEcCtD
Clomipramine—Nervous system disorder—Doxorubicin—stomach cancer	4.51e-05	0.000245	CcSEcCtD
Clomipramine—Thrombocytopenia—Doxorubicin—stomach cancer	4.5e-05	0.000244	CcSEcCtD
Clomipramine—Rash—Capecitabine—stomach cancer	4.5e-05	0.000244	CcSEcCtD
Clomipramine—Insomnia—Epirubicin—stomach cancer	4.49e-05	0.000244	CcSEcCtD
Clomipramine—Dermatitis—Capecitabine—stomach cancer	4.49e-05	0.000244	CcSEcCtD
Clomipramine—Tachycardia—Doxorubicin—stomach cancer	4.49e-05	0.000244	CcSEcCtD
Clomipramine—Headache—Capecitabine—stomach cancer	4.47e-05	0.000243	CcSEcCtD
Clomipramine—Skin disorder—Doxorubicin—stomach cancer	4.46e-05	0.000242	CcSEcCtD
Clomipramine—Paraesthesia—Epirubicin—stomach cancer	4.46e-05	0.000242	CcSEcCtD
Clomipramine—Hyperhidrosis—Doxorubicin—stomach cancer	4.44e-05	0.000241	CcSEcCtD
Clomipramine—Dyspnoea—Epirubicin—stomach cancer	4.43e-05	0.00024	CcSEcCtD
Clomipramine—Somnolence—Epirubicin—stomach cancer	4.42e-05	0.00024	CcSEcCtD
Clomipramine—Anorexia—Doxorubicin—stomach cancer	4.38e-05	0.000238	CcSEcCtD
Clomipramine—Nausea—Docetaxel—stomach cancer	4.37e-05	0.000238	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—stomach cancer	4.37e-05	0.000237	CcSEcCtD
Clomipramine—Dyspepsia—Epirubicin—stomach cancer	4.37e-05	0.000237	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—stomach cancer	4.34e-05	0.000236	CcSEcCtD
Clomipramine—Decreased appetite—Epirubicin—stomach cancer	4.32e-05	0.000234	CcSEcCtD
Clomipramine—Hypotension—Doxorubicin—stomach cancer	4.29e-05	0.000233	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Epirubicin—stomach cancer	4.29e-05	0.000233	CcSEcCtD
Clomipramine—Fatigue—Epirubicin—stomach cancer	4.28e-05	0.000233	CcSEcCtD
Clomipramine—Pain—Epirubicin—stomach cancer	4.25e-05	0.000231	CcSEcCtD
Clomipramine—Constipation—Epirubicin—stomach cancer	4.25e-05	0.000231	CcSEcCtD
Clomipramine—Nausea—Capecitabine—stomach cancer	4.23e-05	0.00023	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—stomach cancer	4.22e-05	0.000229	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—stomach cancer	4.2e-05	0.000228	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—stomach cancer	4.2e-05	0.000228	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.19e-05	0.000227	CcSEcCtD
Clomipramine—Insomnia—Doxorubicin—stomach cancer	4.16e-05	0.000226	CcSEcCtD
Clomipramine—Paraesthesia—Doxorubicin—stomach cancer	4.13e-05	0.000224	CcSEcCtD
Clomipramine—Dyspnoea—Doxorubicin—stomach cancer	4.1e-05	0.000222	CcSEcCtD
Clomipramine—Feeling abnormal—Epirubicin—stomach cancer	4.09e-05	0.000222	CcSEcCtD
Clomipramine—Somnolence—Doxorubicin—stomach cancer	4.09e-05	0.000222	CcSEcCtD
Clomipramine—Gastrointestinal pain—Epirubicin—stomach cancer	4.06e-05	0.000221	CcSEcCtD
Clomipramine—Dyspepsia—Doxorubicin—stomach cancer	4.05e-05	0.00022	CcSEcCtD
Clomipramine—Decreased appetite—Doxorubicin—stomach cancer	3.99e-05	0.000217	CcSEcCtD
Clomipramine—Diazepam—ALB—stomach cancer	3.97e-05	0.0111	CrCbGaD
Clomipramine—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.97e-05	0.000215	CcSEcCtD
Clomipramine—Fatigue—Doxorubicin—stomach cancer	3.96e-05	0.000215	CcSEcCtD
Clomipramine—Urticaria—Epirubicin—stomach cancer	3.95e-05	0.000214	CcSEcCtD
Clomipramine—Constipation—Doxorubicin—stomach cancer	3.93e-05	0.000213	CcSEcCtD
Clomipramine—Pain—Doxorubicin—stomach cancer	3.93e-05	0.000213	CcSEcCtD
Clomipramine—Abdominal pain—Epirubicin—stomach cancer	3.93e-05	0.000213	CcSEcCtD
Clomipramine—Body temperature increased—Epirubicin—stomach cancer	3.93e-05	0.000213	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—stomach cancer	3.91e-05	0.000212	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—stomach cancer	3.81e-05	0.000207	CcSEcCtD
Clomipramine—Feeling abnormal—Doxorubicin—stomach cancer	3.79e-05	0.000206	CcSEcCtD
Clomipramine—Gastrointestinal pain—Doxorubicin—stomach cancer	3.76e-05	0.000204	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—stomach cancer	3.75e-05	0.000204	CcSEcCtD
Clomipramine—Chlorpromazine—ALB—stomach cancer	3.69e-05	0.0103	CrCbGaD
Clomipramine—Hypersensitivity—Epirubicin—stomach cancer	3.66e-05	0.000199	CcSEcCtD
Clomipramine—Urticaria—Doxorubicin—stomach cancer	3.65e-05	0.000198	CcSEcCtD
Clomipramine—Amitriptyline—ALB—stomach cancer	3.65e-05	0.0102	CrCbGaD
Clomipramine—Body temperature increased—Doxorubicin—stomach cancer	3.63e-05	0.000197	CcSEcCtD
Clomipramine—Abdominal pain—Doxorubicin—stomach cancer	3.63e-05	0.000197	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—stomach cancer	3.63e-05	0.000197	CcSEcCtD
Clomipramine—Asthenia—Epirubicin—stomach cancer	3.56e-05	0.000194	CcSEcCtD
Clomipramine—Pruritus—Epirubicin—stomach cancer	3.51e-05	0.000191	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—stomach cancer	3.51e-05	0.000191	CcSEcCtD
Clomipramine—Diarrhoea—Epirubicin—stomach cancer	3.4e-05	0.000185	CcSEcCtD
Clomipramine—Hypersensitivity—Doxorubicin—stomach cancer	3.39e-05	0.000184	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—stomach cancer	3.37e-05	0.000183	CcSEcCtD
Clomipramine—Rash—Methotrexate—stomach cancer	3.35e-05	0.000182	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—stomach cancer	3.34e-05	0.000182	CcSEcCtD
Clomipramine—Headache—Methotrexate—stomach cancer	3.32e-05	0.000181	CcSEcCtD
Clomipramine—Asthenia—Doxorubicin—stomach cancer	3.3e-05	0.000179	CcSEcCtD
Clomipramine—Dizziness—Epirubicin—stomach cancer	3.28e-05	0.000178	CcSEcCtD
Clomipramine—Pruritus—Doxorubicin—stomach cancer	3.25e-05	0.000177	CcSEcCtD
Clomipramine—Vomiting—Epirubicin—stomach cancer	3.16e-05	0.000171	CcSEcCtD
Clomipramine—Nausea—Methotrexate—stomach cancer	3.15e-05	0.000171	CcSEcCtD
Clomipramine—Diarrhoea—Doxorubicin—stomach cancer	3.14e-05	0.000171	CcSEcCtD
Clomipramine—Rash—Epirubicin—stomach cancer	3.13e-05	0.00017	CcSEcCtD
Clomipramine—Dermatitis—Epirubicin—stomach cancer	3.13e-05	0.00017	CcSEcCtD
Clomipramine—Headache—Epirubicin—stomach cancer	3.11e-05	0.000169	CcSEcCtD
Clomipramine—Dizziness—Doxorubicin—stomach cancer	3.04e-05	0.000165	CcSEcCtD
Clomipramine—Nausea—Epirubicin—stomach cancer	2.95e-05	0.00016	CcSEcCtD
Clomipramine—Vomiting—Doxorubicin—stomach cancer	2.92e-05	0.000159	CcSEcCtD
Clomipramine—Rash—Doxorubicin—stomach cancer	2.9e-05	0.000157	CcSEcCtD
Clomipramine—Dermatitis—Doxorubicin—stomach cancer	2.89e-05	0.000157	CcSEcCtD
Clomipramine—Headache—Doxorubicin—stomach cancer	2.88e-05	0.000156	CcSEcCtD
Clomipramine—Nausea—Doxorubicin—stomach cancer	2.73e-05	0.000148	CcSEcCtD
Clomipramine—HTR2B—Signaling by GPCR—PIK3CA—stomach cancer	4.84e-06	5.75e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALOX5—stomach cancer	4.83e-06	5.74e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	4.82e-06	5.73e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CDKN1B—stomach cancer	4.82e-06	5.73e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPP2R1A—stomach cancer	4.82e-06	5.73e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—stomach cancer	4.81e-06	5.71e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HMOX1—stomach cancer	4.78e-06	5.67e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DPYD—stomach cancer	4.75e-06	5.65e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ERBB2—stomach cancer	4.75e-06	5.65e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK3—stomach cancer	4.73e-06	5.62e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTP1—stomach cancer	4.73e-06	5.62e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CAV1—stomach cancer	4.71e-06	5.59e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK1—stomach cancer	4.71e-06	5.59e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—EGFR—stomach cancer	4.7e-06	5.59e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOA1—stomach cancer	4.7e-06	5.58e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—stomach cancer	4.69e-06	5.58e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HMOX1—stomach cancer	4.66e-06	5.54e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ERCC2—stomach cancer	4.66e-06	5.54e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—KRAS—stomach cancer	4.62e-06	5.48e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCND1—stomach cancer	4.6e-06	5.46e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—JUN—stomach cancer	4.59e-06	5.45e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6R—stomach cancer	4.58e-06	5.45e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.54e-06	5.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CD44—stomach cancer	4.52e-06	5.38e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL8—stomach cancer	4.51e-06	5.35e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TYMS—stomach cancer	4.5e-06	5.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PPARG—stomach cancer	4.5e-06	5.35e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK1—stomach cancer	4.5e-06	5.35e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—EGFR—stomach cancer	4.5e-06	5.34e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRKCB—stomach cancer	4.48e-06	5.32e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—stomach cancer	4.48e-06	5.32e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—stomach cancer	4.46e-06	5.3e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6ST—stomach cancer	4.46e-06	5.3e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—stomach cancer	4.45e-06	5.29e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—stomach cancer	4.45e-06	5.29e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CDKN1A—stomach cancer	4.45e-06	5.29e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KRAS—stomach cancer	4.44e-06	5.28e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	4.42e-06	5.25e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDKN1B—stomach cancer	4.4e-06	5.23e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TYMS—stomach cancer	4.39e-06	5.22e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—stomach cancer	4.39e-06	5.22e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.39e-06	5.22e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—stomach cancer	4.38e-06	5.21e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—stomach cancer	4.34e-06	5.16e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK8—stomach cancer	4.34e-06	5.16e-05	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PIK3CA—stomach cancer	4.3e-06	5.11e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SERPINE1—stomach cancer	4.29e-06	5.1e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APC—stomach cancer	4.29e-06	5.09e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—stomach cancer	4.28e-06	5.09e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	4.28e-06	5.09e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	4.27e-06	5.08e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—KRAS—stomach cancer	4.25e-06	5.05e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—PIK3CA—stomach cancer	4.24e-06	5.04e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTT1—stomach cancer	4.2e-06	4.99e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCND1—stomach cancer	4.2e-06	4.99e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—JUN—stomach cancer	4.19e-06	4.98e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ERCC2—stomach cancer	4.18e-06	4.97e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.15e-06	4.93e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TYMS—stomach cancer	4.14e-06	4.92e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RHOA—stomach cancer	4.14e-06	4.92e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK3—stomach cancer	4.11e-06	4.88e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—stomach cancer	4.1e-06	4.87e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NOS3—stomach cancer	4.1e-06	4.87e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—stomach cancer	4.09e-06	4.86e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ERCC2—stomach cancer	4.08e-06	4.85e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PIK3CA—stomach cancer	4.08e-06	4.85e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	4.08e-06	4.84e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—stomach cancer	4.08e-06	4.84e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CDKN1A—stomach cancer	4.06e-06	4.83e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	4.06e-06	4.82e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—stomach cancer	4.05e-06	4.81e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CAV1—stomach cancer	4.04e-06	4.8e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.04e-06	4.8e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOA1—stomach cancer	4.03e-06	4.79e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—stomach cancer	4.01e-06	4.76e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6R—stomach cancer	3.98e-06	4.73e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—stomach cancer	3.97e-06	4.72e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK8—stomach cancer	3.96e-06	4.71e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—stomach cancer	3.95e-06	4.69e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ENO1—stomach cancer	3.94e-06	4.68e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—stomach cancer	3.93e-06	4.67e-05	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—stomach cancer	3.92e-06	4.66e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	3.91e-06	4.64e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EGFR—stomach cancer	3.91e-06	4.64e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PIK3CA—stomach cancer	3.9e-06	4.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APC—stomach cancer	3.9e-06	4.63e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NOS3—stomach cancer	3.87e-06	4.6e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.86e-06	4.59e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ERCC2—stomach cancer	3.85e-06	4.57e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.85e-06	4.57e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—stomach cancer	3.84e-06	4.56e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ERBB2—stomach cancer	3.83e-06	4.55e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK3—stomach cancer	3.79e-06	4.51e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—stomach cancer	3.78e-06	4.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—stomach cancer	3.77e-06	4.48e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	3.74e-06	4.44e-05	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	3.73e-06	4.44e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	3.73e-06	4.43e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—stomach cancer	3.72e-06	4.42e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—KRAS—stomach cancer	3.69e-06	4.38e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—stomach cancer	3.69e-06	4.38e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—stomach cancer	3.66e-06	4.35e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL8—stomach cancer	3.64e-06	4.32e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CAV1—stomach cancer	3.63e-06	4.31e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—stomach cancer	3.62e-06	4.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	3.62e-06	4.3e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOA1—stomach cancer	3.62e-06	4.3e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—stomach cancer	3.62e-06	4.3e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—stomach cancer	3.62e-06	4.3e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—stomach cancer	3.61e-06	4.29e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—stomach cancer	3.61e-06	4.29e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EGFR—stomach cancer	3.61e-06	4.29e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RHOA—stomach cancer	3.6e-06	4.27e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NOS3—stomach cancer	3.56e-06	4.23e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	3.55e-06	4.22e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	3.55e-06	4.22e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PPARG—stomach cancer	3.55e-06	4.22e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	3.55e-06	4.22e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PTGS2—stomach cancer	3.54e-06	4.21e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CAV1—stomach cancer	3.54e-06	4.21e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOA1—stomach cancer	3.53e-06	4.2e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TYMS—stomach cancer	3.51e-06	4.17e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CD44—stomach cancer	3.49e-06	4.15e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—stomach cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.46e-06	4.11e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—stomach cancer	3.46e-06	4.11e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KRAS—stomach cancer	3.41e-06	4.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	3.4e-06	4.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	3.39e-06	4.03e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	3.39e-06	4.03e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCND1—stomach cancer	3.39e-06	4.02e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—JUN—stomach cancer	3.38e-06	4.02e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—stomach cancer	3.37e-06	4e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	3.36e-06	3.99e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CAV1—stomach cancer	3.34e-06	3.96e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOA1—stomach cancer	3.33e-06	3.96e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	3.33e-06	3.96e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3.29e-06	3.91e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EGFR—stomach cancer	3.29e-06	3.91e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—stomach cancer	3.29e-06	3.91e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	3.28e-06	3.89e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	3.27e-06	3.89e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ERCC2—stomach cancer	3.26e-06	3.87e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	3.24e-06	3.85e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	3.2e-06	3.8e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PPARG—stomach cancer	3.19e-06	3.79e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	3.14e-06	3.73e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PIK3CA—stomach cancer	3.13e-06	3.72e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PPARG—stomach cancer	3.11e-06	3.7e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KRAS—stomach cancer	3.11e-06	3.7e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	3.08e-06	3.66e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	3.08e-06	3.66e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—stomach cancer	3.06e-06	3.64e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NOS3—stomach cancer	3.06e-06	3.63e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—stomach cancer	3.03e-06	3.6e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	3.03e-06	3.6e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—stomach cancer	3e-06	3.57e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.97e-06	3.53e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	2.95e-06	3.51e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.94e-06	3.49e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—JUN—stomach cancer	2.93e-06	3.49e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PPARG—stomach cancer	2.93e-06	3.49e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—stomach cancer	2.91e-06	3.46e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—stomach cancer	2.9e-06	3.44e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—stomach cancer	2.87e-06	3.41e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.87e-06	3.41e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—stomach cancer	2.87e-06	3.41e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	2.86e-06	3.4e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.86e-06	3.39e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.85e-06	3.39e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.84e-06	3.38e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CAV1—stomach cancer	2.83e-06	3.36e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOA1—stomach cancer	2.82e-06	3.35e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.8e-06	3.33e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—stomach cancer	2.8e-06	3.33e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PTGS2—stomach cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.79e-06	3.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.78e-06	3.3e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—stomach cancer	2.77e-06	3.29e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—stomach cancer	2.77e-06	3.29e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NOS3—stomach cancer	2.74e-06	3.26e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.73e-06	3.24e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—stomach cancer	2.72e-06	3.23e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TYMS—stomach cancer	2.71e-06	3.22e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.7e-06	3.21e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NOS3—stomach cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—stomach cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.67e-06	3.17e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.64e-06	3.14e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—stomach cancer	2.64e-06	3.13e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.6e-06	3.09e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.59e-06	3.08e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.56e-06	3.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.54e-06	3.02e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—stomach cancer	2.53e-06	3.01e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.53e-06	3e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NOS3—stomach cancer	2.52e-06	3e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.52e-06	2.99e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.51e-06	2.98e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PTGS2—stomach cancer	2.51e-06	2.98e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PPARG—stomach cancer	2.49e-06	2.95e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PTGS2—stomach cancer	2.45e-06	2.91e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.43e-06	2.88e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.37e-06	2.81e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—stomach cancer	2.36e-06	2.8e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	2.33e-06	2.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PTGS2—stomach cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—stomach cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—stomach cancer	2.23e-06	2.65e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	2.21e-06	2.62e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CAV1—stomach cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOA1—stomach cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.15e-06	2.55e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NOS3—stomach cancer	2.14e-06	2.54e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—stomach cancer	2.13e-06	2.53e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—stomach cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2e-06	2.38e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.98e-06	2.36e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PTGS2—stomach cancer	1.95e-06	2.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—stomach cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PPARG—stomach cancer	1.92e-06	2.28e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.85e-06	2.2e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.82e-06	2.16e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—stomach cancer	1.77e-06	2.11e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.76e-06	2.09e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—stomach cancer	1.72e-06	2.05e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3CA—stomach cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.69e-06	2e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NOS3—stomach cancer	1.65e-06	1.96e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.61e-06	1.92e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.54e-06	1.83e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3CA—stomach cancer	1.51e-06	1.79e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.42e-06	1.69e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.2e-06	1.43e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.28e-07	1.1e-05	CbGpPWpGaD
